BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 34186148)

  • 1. Focused ultrasound with anti-pGlu3 Aβ enhances efficacy in Alzheimer's disease-like mice via recruitment of peripheral immune cells.
    Sun T; Shi Q; Zhang Y; Power C; Hoesch C; Antonelli S; Schroeder MK; Caldarone BJ; Taudte N; Schenk M; Hettmann T; Schilling S; McDannold NJ; Lemere CA
    J Control Release; 2021 Aug; 336():443-456. PubMed ID: 34186148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute Effects of Focused Ultrasound-Induced Blood-Brain Barrier Opening on Anti-Pyroglu3 Abeta Antibody Delivery and Immune Responses.
    Bathini P; Sun T; Schenk M; Schilling S; McDannold NJ; Lemere CA
    Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effector function of anti-pyroglutamate-3 Aβ antibodies affects cognitive benefit, glial activation and amyloid clearance in Alzheimer's-like mice.
    Crehan H; Liu B; Kleinschmidt M; Rahfeld JU; Le KX; Caldarone BJ; Frost JL; Hettmann T; Hutter-Paier B; O'Nuallain B; Park MA; DiCarli MF; Lues I; Schilling S; Lemere CA
    Alzheimers Res Ther; 2020 Jan; 12(1):12. PubMed ID: 31931873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease.
    Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X
    Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focused ultrasound mitigates pathology and improves spatial memory in Alzheimer's mice and patients.
    Karakatsani ME; Ji R; Murillo MF; Kugelman T; Kwon N; Lao YH; Liu K; Pouliopoulos AN; Honig LS; Duff KE; Konofagou EE
    Theranostics; 2023; 13(12):4102-4120. PubMed ID: 37554284
    [No Abstract]   [Full Text] [Related]  

  • 6. Ultrasound-mediated augmented exosome release from astrocytes alleviates amyloid-β-induced neurotoxicity.
    Deng Z; Wang J; Xiao Y; Li F; Niu L; Liu X; Meng L; Zheng H
    Theranostics; 2021; 11(9):4351-4362. PubMed ID: 33754065
    [No Abstract]   [Full Text] [Related]  

  • 7. Amyloid-β plaque reduction, endogenous antibody delivery and glial activation by brain-targeted, transcranial focused ultrasound.
    Jordão JF; Thévenot E; Markham-Coultes K; Scarcelli T; Weng YQ; Xhima K; O'Reilly M; Huang Y; McLaurin J; Hynynen K; Aubert I
    Exp Neurol; 2013 Oct; 248():16-29. PubMed ID: 23707300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced delivery of a low dose of aducanumab via FUS in 5×FAD mice, an AD model.
    Kong C; Yang EJ; Shin J; Park J; Kim SH; Park SW; Chang WS; Lee CH; Kim H; Kim HS; Chang JW
    Transl Neurodegener; 2022 Dec; 11(1):57. PubMed ID: 36575534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FUS-mediated blood-brain barrier disruption for delivering anti-Aβ antibodies in 5XFAD Alzheimer's disease mice.
    Antoniou A; Stavrou M; Evripidou N; Georgiou E; Kousiappa I; Koupparis A; Papacostas SS; Kleopa KA; Damianou C
    J Ultrasound; 2023 Jul; ():. PubMed ID: 37516718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Passive immunization against pyroglutamate-3 amyloid-β reduces plaque burden in Alzheimer-like transgenic mice: a pilot study.
    Frost JL; Liu B; Kleinschmidt M; Schilling S; Demuth HU; Lemere CA
    Neurodegener Dis; 2012; 10(1-4):265-70. PubMed ID: 22343072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focused ultrasound-mediated blood-brain barrier opening in Alzheimer's disease: long-term safety, imaging, and cognitive outcomes.
    Rezai AR; Ranjan M; Haut MW; Carpenter J; D'Haese PF; Mehta RI; Najib U; Wang P; Claassen DO; Chazen JL; Krishna V; Deib G; Zibly Z; Hodder SL; Wilhelmsen KC; Finomore V; Konrad PE; Kaplitt M;
    J Neurosurg; 2023 Jul; 139(1):275-283. PubMed ID: 36334289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies targeted to the brain with image-guided focused ultrasound reduces amyloid-beta plaque load in the TgCRND8 mouse model of Alzheimer's disease.
    Jordão JF; Ayala-Grosso CA; Markham K; Huang Y; Chopra R; McLaurin J; Hynynen K; Aubert I
    PLoS One; 2010 May; 5(5):e10549. PubMed ID: 20485502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylene Blue Delivery Mediated by Focused Ultrasound-Induced Blood-Brain Barrier Disruption Reduces Neural Damage and Amyloid-Beta Plaques by AQP-4 Upregulation.
    Choi HJ; Han M; Jung B; Hong YR; Shin S; Lim S; Lee EH; Kim YK; Park J
    Biomedicines; 2022 Dec; 10(12):. PubMed ID: 36551947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of the effects of Aducanumab and scanning ultrasound on amyloid plaques and behavior in the APP23 mouse model of Alzheimer disease.
    Leinenga G; Koh WK; Götz J
    Alzheimers Res Ther; 2021 Apr; 13(1):76. PubMed ID: 33836798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S14G-humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice.
    Zhang W; Zhang W; Li Z; Hao J; Zhang Z; Liu L; Mao N; Miao J; Zhang L
    Pharmacol Biochem Behav; 2012 Jan; 100(3):361-9. PubMed ID: 21993310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disaggregation of amyloid plaque in brain of Alzheimer's disease transgenic mice with daily subcutaneous administration of a tetravalent bispecific antibody that targets the transferrin receptor and the Abeta amyloid peptide.
    Sumbria RK; Hui EK; Lu JZ; Boado RJ; Pardridge WM
    Mol Pharm; 2013 Sep; 10(9):3507-13. PubMed ID: 23924247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focused Ultrasound-Induced Blood-Brain Barrier Opening Enhances GSK-3 Inhibitor Delivery for Amyloid-Beta Plaque Reduction.
    Hsu PH; Lin YT; Chung YH; Lin KJ; Yang LY; Yen TC; Liu HL
    Sci Rep; 2018 Aug; 8(1):12882. PubMed ID: 30150769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effects of glatiramer acetate and grafted CD115⁺ monocytes in a mouse model of Alzheimer's disease.
    Koronyo Y; Salumbides BC; Sheyn J; Pelissier L; Li S; Ljubimov V; Moyseyev M; Daley D; Fuchs DT; Pham M; Black KL; Rentsendorj A; Koronyo-Hamaoui M
    Brain; 2015 Aug; 138(Pt 8):2399-422. PubMed ID: 26049087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.